Rimonabant in Obesity Over a 2-Year Duration (RIO-Europe)
NCT00386061
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
1507
Enrollment
INDUSTRY
Sponsor class
Conditions
Obesity
Interventions
DRUG:
rimonabant (SR141716)
Sponsor
Sanofi